Prestige Consumer Healthcare Inc. (Prestige Brands Holdings, Inc.) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for the period ended June 30, 2007. Prestige Brands Holdings, Inc. is a holding company engaged in the marketing, sales, and distribution of over-the-counter (OTC) healthcare, personal care, and household cleaning brands. The company operates primarily in the United States and Canada, selling to mass merchandisers, drug stores, and supermarkets.
Key Financial Metrics
| Metric | Q2 2007 | Q2 2006 |
|---|---|---|
| Total Revenues | $78.6 million | $75.9 million |
| Net Sales | $78.0 million | $75.6 million |
| Gross Profit | $41.3 million | $39.6 million |
| Gross Margin | 52.5% | 52.2% |
| Operating Income | $23.1 million | $23.3 million |
| Net Income | $8.3 million | $8.3 million |
| Diluted EPS | $0.17 | $0.17 |
| Cash from Operations | $8.4 million | $21.5 million |
| Total Debt (Outstanding) | $447.5 million | $463.4 million (Mar 31, 2007) |
| Cash and Equivalents | $6.2 million | $13.8 million (Mar 31, 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 3.5% year-over-year, driven primarily by the September 2006 acquisition of the Wartner brand. Excluding Wartner, revenues declined 0.5%.
- Segment Performance:
- OTC Healthcare: Revenues increased 7.1% to $42.4 million, led by Wartner, Compound W, and Little Remedies.
- Household Cleaning: Revenues declined 0.7% to $29.9 million due to lower Chore Boy sales compared to a strong prior year.
- Personal Care: Revenues increased 1.1% to $6.3 million.
- Operating Expenses: General and administrative expenses rose 18.8% to $7.6 million, attributed to higher stock-based compensation and legal costs. Advertising and promotion expenses increased 5.2% to $7.8 million.
- Cash Flow: Net cash provided by operating activities decreased significantly by $13.1 million to $8.4 million. This was primarily due to a reduction in operating liabilities (paying down accounts payable and accrued liabilities) compared to the prior year.
- Debt Reduction: The company repaid $15.0 million of indebtedness in excess of normal maturities, reducing total debt from $463.4 million to $447.5 million.
Outlook, Risks, and Contingencies
- Legal Proceedings: In the OraSure Technologies litigation regarding the Wartner brand, the Appellate Division of the Supreme Court of New York vacated a preliminary injunction that would have prohibited sales. An arbitration hearing is scheduled for August 2007.
- Debt Covenants: The company is in compliance with financial covenants, including a leverage ratio of less than 5.0 to 1.0 and an interest coverage ratio greater than 2.75 to 1.0.
- Market Risks: The company faces exposure to variable interest rates on $321.5 million of debt, partially hedged by interest rate caps. A 1% increase in rates would impact pre-tax earnings by approximately $2.7 million (net of caps). Inflationary pressures on raw materials and transportation costs are also noted.
- Concentration Risk: Approximately 24.9% of net sales were made to a single customer, and 56.5% of sales were derived from four major brands.
Investor Verification Checklist
- Wartner Litigation Outcome: Monitor the results of the August 2007 arbitration hearing regarding the Wartner brand intellectual property.
- Debt Servicing Capacity: Verify the company's ability to maintain leverage and interest coverage ratios given the high debt load ($447.5 million) and variable interest rate exposure.
- Customer Concentration: Assess the risk associated with the single customer representing nearly 25% of net sales.
- Organic Growth: Evaluate underlying sales trends excluding the Wartner acquisition, as organic revenues declined slightly in the quarter.
- Working Capital Management: Review the significant decrease in operating cash flow caused by the reduction of operating liabilities to ensure it is not a recurring trend impacting liquidity.